Obinutuzumab Plus Chemotherapy Compared with Rituximab Plus Chemotherapy in Previously Untreated Italian Patients with Advanced Follicular Lymphoma at Intermediate–High Risk: A Cost-Effectiveness Analysis
Keyword(s):
2020 ◽
Vol 227
◽
pp. 176-183.e3
◽
2019 ◽
Vol 15
(4)
◽
pp. 863-872
◽
2014 ◽
Vol 42
(5)
◽
pp. 1194-1203
◽
2020 ◽